What is Translational Software?
Founded in 2009, Translational Software operates at the intersection of bioinformatics and clinical informatics. The company provides a sophisticated software layer that translates raw, complex genetic data into actionable, evidence-based recommendations. By offering a platform-agnostic solution, the firm enables healthcare providers to integrate genomic insights seamlessly into existing electronic health record workflows. This capability is essential for the advancement of precision medicine, as it removes the technical barriers that often prevent clinicians from utilizing genetic information to inform therapeutic decisions. The company's market position is defined by its commitment to interoperability and its ability to simplify the interpretation of high-throughput sequencing data for practical, bedside utility.
How much funding has Translational Software raised?
Translational Software has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Translational Software
PPP
Public-Private Partnership
What's next for Translational Software?
With the recent injection of capital, Translational Software is well-positioned to transition into a phase of aggressive market penetration and technological refinement. The strategic roadmap likely involves deepening the integration of its decision support tools with major health information exchanges and expanding its library of clinical guidelines. As the healthcare industry continues to prioritize personalized treatment protocols, the demand for reliable, scalable genomic interpretation software is expected to rise. The company will likely focus on enhancing its data processing capabilities to handle increasingly complex multi-omic datasets, thereby maintaining its competitive edge in the rapidly evolving health IT sector. Future growth will be predicated on the firm's ability to maintain its platform-agnostic status while fostering deeper partnerships with diagnostic laboratories and clinical research organizations.
See full Translational Software company page
